Last reviewed · How we verify

NCT01186211

Feasibility of Outpatient Total Knee Arthroplasty

Completed Last updated 6 September 2019
What this trial tests

trial in Osteoarthritis Of Knee in 177 participants. Completed in 18 June 2019.

Timeline
1 November 2010
Primary endpoint
18 June 2019
18 June 2019

Quick facts

Lead sponsorOttawa Hospital Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment177
Start date1 November 2010
Primary completion18 June 2019
Estimated completion18 June 2019
Sites1 location across Canada

Conditions studied

Sponsor

Ottawa Hospital Research Institute

Who can join

Adults 50 to 75, any sex, with Osteoarthritis Of Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This proposal outlines the investigators plan to develop, evaluate and implement an accelerated in hospital and community rehabilitation following total knee arthroplasty (TKA) leading to outpatient TKA. The benefits of applying current concepts of improved postoperative analgesia and less invasive surgical technique are expected to improve objective parameters of knee function, increase patients satisfaction, while reducing health care resources requirements as compared with standard rehabilitation. The innovation of combining best practices from orthopaedic sports medicine, Anesthesia, Physiotherapy and Knee reconstruction are expected to realize this goal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis Of Knee

Currently open trials in the same condition.

Other Ottawa Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01186211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing